Form 8-K · Current report
News Corp 8-K, filed Sep 10, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000198
Summary
News Corp filed an 8-K disclosing daily buy-back notifications to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes up to US$1 billion of Nasdaq-listed Class A and Class B common stock. The filing reports 58,482 shares bought back on September 9, 2026 for US$1,731,096.44, bringing total repurchases under the program to approximately US$468.5 million.
Key points
- News Corp's 2025 Repurchase Program authorizes up to an aggregate of US$1 billion of Class A and Class B common stock.
- On September 9, 2026, News Corp bought back 58,482 shares for US$1,731,096.44.
- Cumulative buy-backs to date total 11,727,932 shares for US$304,671,186.67 through the previous day, and approximately US$468,463,939 based on total consideration paid under the 2025 Repurchase Program.
- Goldman Sachs & Co. LLC is named as broker for the on-market repurchase.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.